KLK3 and posterior cortical atrophy: Two patients had long-term responses with sustained >50% reductions in PSA for 50 weeks and >80 weeks.52,53 AMG212 was the first BiTE monotherapy in clinical study to demonstrate efficacy in patients with PCa.